ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,980Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 890

$1.19M Total Retail Price of All Prescriptions

Rank: 26 out of 890

468 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 468 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 11,400 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
CRESTOR 715 374 1 25
NEXIUM 634 374 2 14
FUROSEMIDE 620 419 3 7
METOPROLOL TARTRATE 593 404 4 15
PRAVASTATIN SODIUM 562 351 5 10
ENALAPRIL MALEATE 478 322 6 56
OMEPRAZOLE 387 250 7 8
METFORMIN HCL 384 270 8 6
AMLODIPINE BESYLATE 381 250 9 1
LISINOPRIL 311 213 10 4
SIMVASTATIN 308 191 11 5
POTASSIUM CHLORIDE 307 206 12 11
LEVOTHYROXINE SODIUM 303 209 13 2
ZOLPIDEM TARTRATE 289 149 14 19
CARVEDILOL 272 161 15 22
GABAPENTIN 253 117 16 12
ESCITALOPRAM OXALATE 253 141 16 51
WARFARIN SODIUM 232 189 18 24
LOSARTAN-HYDROCHLOROTHIAZIDE 232 127 18 57
IBUPROFEN 224 115 20 101
CITALOPRAM HBR 219 94 21 20
TRILIPIX 219 115 21 200
TAMSULOSIN HCL 205 174 23 32
ATENOLOL 201 112 24 23
SPIRONOLACTONE 190 108 25 85
ZETIA 183 128 26 81
ETODOLAC 177 143 27 197
CLOPIDOGREL 174 90 28 28
SERTRALINE HCL 174 78 28 26
SYMBICORT 167 90 30 174
HYDROCHLOROTHIAZIDE 161 103 31 9
ALLOPURINOL 147 79 32 31
DIVALPROEX SODIUM 142 16 33 126
PAROXETINE HCL 136 81 34 68
JANUVIA 132 117 35 59
ATORVASTATIN CALCIUM 127 107 36 13
NASONEX 125 50 37 170
CYCLOBENZAPRINE HCL 120 72 R 38 64
LOVASTATIN 118 49 39 46
RISPERIDONE 117 0 40 78
NAPROXEN 116 46 41 84
SINGULAIR 116 44 41 79
MELOXICAM 113 71 43 18
GLIPIZIDE 110 101 44 62
PLAVIX 110 75 44 42
FINASTERIDE 109 100 46 108
QUETIAPINE FUMARATE 107 40 47 73
TRAMADOL HCL-ACETAMINOPHEN 105 63 48 117
METOPROLOL SUCCINATE 105 86 48 17
LOSARTAN POTASSIUM 104 72 50 29
GEMFIBROZIL 103 44 51 103
VESICARE 101 77 52 188
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 48 53 21
CLONIDINE HCL 95 72 54 35
AMITRIPTYLINE HCL 87 65 R 55 43
METOCLOPRAMIDE HCL 84 45 56 125
PROAIR HFA 78 46 57 55
ISOSORBIDE MONONITRATE ER 78 74 57 60
TRIAMCINOLONE ACETONIDE 77 54 59 160
AMOXICILLIN 77 41 59 94
ONGLYZA 76 53 61 146
TRICOR 75 51 62 98
RANITIDINE HCL 74 56 63 49
ROPINIROLE HCL 74 36 63 93
HYDRALAZINE HCL 74 62 63 100
LEXAPRO 73 44 66 186
ALENDRONATE SODIUM 71 62 67 38
PREMARIN 71 18 R 67 105
LANTUS 69 45 69 50
DILTIAZEM 24HR ER 68 65 70 149
OXYBUTYNIN CHLORIDE ER 68 28 70 154
CYMBALTA 68 24 70 45
THEOPHYLLINE ANHYDROUS 68 54 70 243
PHENYTOIN SODIUM EXTENDED 68 11 70 111
LYRICA 67 25 75 71
TERAZOSIN HCL 66 66 76 142
AVODART 66 66 76 198
GLIMEPIRIDE 65 32 78 27
DONEPEZIL HCL 65 57 78 30
KLOR-CON M20 64 37 80 72
SPIRIVA 62 47 81 66
MONTELUKAST SODIUM 59 16 82 130
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 23 83 76
MIRTAZAPINE 58 28 83 82
NAMENDA 57 42 85 36
COMBIVENT 57 19 85 144
ACTOS 57 52 85 88
BENZTROPINE MESYLATE 57 0 R 85 196
DICYCLOMINE HCL 56 25 89 295
FLUTICASONE PROPIONATE 56 33 89 39
ADVAIR DISKUS 52 36 91 52
NIFEDIPINE ER 52 52 91 75
AMOX TR-POTASSIUM CLAVULANATE 52 27 91 132
ESTRADIOL 51 41 R 94 118
ENALAPRIL-HYDROCHLOROTHIAZIDE 50 49 95 230
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.